2026 NPPES data Dermatology Physician NPI 1720080476 M.D.
Verify on CMS →

MARK PENNINGTON, M.D.

Dermatology Physician in NEW BRITAIN, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
918
Medicare Part D claims · 413 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
91%
generic claims · 9% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$225.14
8 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARK PENNINGTON, M.D. filed 918 Medicare Part D claims in 2023 as a Dermatology Physician in NEW BRITAIN, Connecticut, prescribing 91% generic.

918
Part D claims, 2023
91%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK PENNINGTON, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

918 Top 25% higher than 75% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). This entry sits in this band. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

MARK PENNINGTON, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARK PENNINGTON, M.D.?

Quality data not reported

NPI registry status

Active

Issued 08/12/2005

NPI 1720080476

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

918 26% vs specialty avg

2023 prescription claims

Specialty avg: 729

Specialty distribution in Connecticut

How Dermatology Physician compares to other specialties among Connecticut providers

Connecticut providers

Dermatology Physician share within Connecticut

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within Connecticut

Specialty board-certification context

Estimated specialty board-certified rate — Dermatology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Dermatology Physician ABMS/AOA estimate

Est. board-certified rate (Dermatology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Dermatology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK PENNINGTON, M.D. is a Dermatology Physician provider practicing in NEW BRITAIN, Connecticut, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1720080476. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK PENNINGTON, M.D. appears in the CMS NPPES registry as a Dermatology Physician provider holding M.D. credentials at 1 LAKE ST, NEW BRITAIN, CT, 06052, with a listed phone of (860) 348-4242. NPI 1720080476 was issued on 08/12/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PENNINGTON most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 918 prescription claims written by this provider, covering 413 Medicare beneficiaries and totaling roughly $263K in drug spend, split 9% brand-name and 91% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

1 LAKE ST
NEW BRITAIN, CT 06052

Provider Details

NPI 1720080476
Specialty Dermatology Physician
Credentials M.D.
Gender Male
NPI Issued 08/12/2005

Hospital and facility affiliations

Facilities where MARK PENNINGTON, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

STARLING PHYSICIANS, PLLC
AVON, CT

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK PENNINGTON, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$225

Largest payer

E.R. Squibb & Sons, L.L.C.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

MARK PENNINGTON, M.D. — brand share 9.0%
Specialty average (est.)

9% brand-name claims vs 91% generic, on 918 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

918
Total Claims
$263K
Total Drug Cost
413
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
956
Total Day Supply
25,667
Brand vs Generic
9% brand / 91% generic
Brand Drug Cost
$214K
Generic Drug Cost
$50K
Antibiotic Claims
22

Patient Demographics

Average Patient Age
74.9 years
Avg HCC Risk Score
1.15
Gender Split
44% female / 56% male
Age Distribution
<65: 18, 65-74: 187, 75-84: 155, 85+: 53

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Ketoconazole
230
Triamcinolone Acetonide
69
Fluorouracil
64
Clindamycin Phosphate
45
Clobetasol Propionate
43
Ammonium Lactate
42
Fluocinonide
41
Metronidazole
41
Calcipotriene
36
Ciclopirox
22

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How MARK PENNINGTON, M.D. fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

MARK PENNINGTON, M.D.'s 918 claims are above the specialty average of 729.

Nearby Dermatology Physician Providers in Connecticut

Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as PENNINGTON.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK PENNINGTON, M.D.'s specialty?
MARK PENNINGTON, M.D. specializes in Dermatology Physician and practices in NEW BRITAIN, Connecticut. Credentials: M.D..
How much does MARK PENNINGTON, M.D. prescribe under Medicare Part D?
In 2023, MARK PENNINGTON, M.D. wrote 918 Medicare Part D claims totaling $263K in drug costs for 413 beneficiaries.
Where is MARK PENNINGTON, M.D. located?
MARK PENNINGTON, M.D. is located at 1 LAKE ST, NEW BRITAIN, CT, 06052. Phone: (860) 348-4242.
What is MARK PENNINGTON, M.D.'s NPI number?
MARK PENNINGTON, M.D.'s National Provider Identifier (NPI) is 1720080476, issued on 08/12/2005.
Does MARK PENNINGTON, M.D. prescribe more brand-name or generic drugs?
MARK PENNINGTON, M.D.'s prescribing is 9% brand-name and 91% generic drugs by claim count, with $214K in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does MARK PENNINGTON, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARK PENNINGTON, M.D.'s most frequently prescribed drugs include Ketoconazole, Triamcinolone Acetonide, Fluorouracil. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK PENNINGTON, M.D. accept Medicare?
MARK PENNINGTON, M.D. appears in CMS Medicare data with 918 Part D claims and 413 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK PENNINGTON, M.D.'s credentials?
MARK PENNINGTON, M.D.'s NPI is 1720080476 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology